Affirm (AFRM) Insider Notice: 15,000 Common Shares for Sale

Rhea-AI Filing Summary

Affirm Holdings (AFRM) filed a Form 144 notifying a proposed sale of 15,000 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $1,199,850.00. The filer shows total outstanding common shares of 284,917,717, so the proposed sale represents a very small fraction of the outstanding stock. The securities were acquired as restricted stock units on 07/01/2022 (2,048 shares) and from previously exercised stock options on 11/17/2020 (12,952 shares). The filing also discloses a 10b5-1 sale of 754 shares on 07/01/2025 generating gross proceeds of $50,844.63. The filer attests there is no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Proposed sale is immaterial to market capitalization and likely routine executive liquidity.

The Form 144 reports a planned sale of 15,000 common shares valued at roughly $1.2 million against nearly 285 million shares outstanding, indicating minimal dilution or market impact. The lots originate from RSUs and previously exercised options, common sources for insider disposals. The presence of a prior 10b5-1 sale and the attestation about material nonpublic information suggest compliance with standard insider-sale protocols. No financial results or corporate developments are disclosed here to affect valuation.

Corporate Governance Expert

TL;DR: Filing appears procedural and consistent with insider trading rules; no governance red flags evident.

The notice documents an intended sale through a broker and references 10b5-1 activity, which are standard mechanisms for insiders to manage share sales while addressing insider trading concerns. Acquisition dates and types (RSUs and option exercises) are provided, and the signer affirms lack of undisclosed material information. There are no indications of sudden leadership changes, regulatory issues, or material related-party transactions in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	1199850.00	284917717	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2022	Restricted Stock Units	Issuer			2048	07/01/2022	N/A
Common	11/17/2020	Previously Exercised Stock Options	Issuer			12952	11/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTA QUARLES 650 California Street San Francisco CA 94108	Common	07/01/2025	754	50844.63

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the AFRM Form 144 propose to sell?

The filing proposes to sell 15,000 common shares of Affirm Holdings (AFRM) through Morgan Stanley Smith Barney LLC on NASDAQ.

What is the aggregate market value of the proposed sale in the AFRM Form 144?

The aggregate market value is reported as $1,199,850.00.

When were the securities acquired that are being sold according to the Form 144?

The shares were acquired as RSUs on 07/01/2022 (2,048 shares) and from previously exercised options on 11/17/2020 (12,952 shares).

Has the filer sold any AFRM shares recently?

Yes. The filing discloses a 10b5-1 sale of 754 shares on 07/01/2025 with gross proceeds of $50,844.63.

Does the Form 144 indicate any undisclosed material information about AFRM?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.